PROTAC MDM2 Degrader-3 is primarily used in biomedical research to target and degrade the MDM2 protein, which plays a critical role in regulating the tumor suppressor protein p53. By degrading MDM2, this compound helps restore p53 activity, making it a valuable tool in studying cancer therapies, particularly in cancers where p53 is suppressed. Its application extends to investigating protein degradation mechanisms and developing novel therapeutic strategies for p53-dependent cancers. Researchers also utilize it to explore the potential of PROTAC (Proteolysis Targeting Chimeras) technology in drug discovery and targeted protein degradation.